Prevention
Generally, there is no way to prevent
multiple sclerosis (MS) or its attacks. For people
with
relapsing-remitting MS, treatment with interferon beta
or glatiramer acetate may reduce the frequency of relapses, and interferon beta
may delay disability. Interferon beta-1b (Betaseron) or mitoxantrone
(Novantrone) may delay the progression of the disease for some people with
secondary progressive MS. About 4 out of every 10
people with relapsing-remitting MS will progress to secondary progressive MS
within 10 years.10
Claims have been made
that MS may be brought on by injury, shock, pregnancy, or vaccinations, but
there is no scientific evidence to prove these claims. If you already have MS,
a
viral infection (such as the flu) may trigger a
relapse. During pregnancy, women with MS often have fewer relapses. In the
first few months after delivery, however, they may temporarily have more
relapses.2
If you have MS, avoid
overheating your body whenever possible. Increased body temperature can
temporarily make your symptoms worse by causing the nerves already affected by
MS to function even more poorly. Use an air conditioner, keep your home
somewhat cool, and avoid hot swimming pools and hot tubs. During warm or hot
weather, exercise in an air-conditioned area rather than outdoors.
Ropper AH, Brown RH (2005). Multiple sclerosis and
allied demyelinative diseases. In Adams and Victor's Principles of Neurology, 8th ed., pp. 771–796. New York:
McGraw-Hill.
Bennett KA (2005). Pregnancy and multiple sclerosis.
Clinical Obstetrics and Gynecology, 48(1):
38–47.
Giesser B (2003). Reproductive Issues in Persons With Multiple Sclerosis. Clinical Bulletin: Information for
Health Professionals. New York: National Multiple Sclerosis
Society.
Frohman EM (2003). Multiple sclerosis. Medical Clinics of North America, 87(4): 867–897.
McDonald WI, et al. (2001). Recommended diagnostic
criteria for multiple sclerosis: Guidelines from the International Panel on the
Diagnosis of Multiple Sclerosis. Annals of Neurology,
50(1): 121–127.
Polman CH, et al. (2005). Diagnostic criteria for
multiple sclerosis: 2005 revisions to the McDonald Criteria. Annals of Neurology, 58(6): 840–846.
Sadiq SA (2005). Multiple sclerosis. In LP Rowland,
ed., Merritt's Neurology, 11th ed., pp. 941–963.
Philadelphia: Lippincott Williams and Wilkins.
Tintoré M (2003). New diagnostic criteria for multiple
sclerosis: Application in first demyelinating episode. Neurology, 60(1): 27–30.
National Clinical Advisory Board of the National
Multiple Sclerosis Society (2007). Disease Management Consensus Statement. New York: National Multiple Sclerosis Society. Available
online:
http://www.nationalmssociety.org/site/PageServer?pagename=HOM_PRO_expert_opinion_papers.
Lindsey JW, Wolinsky JS (2005). Demyelinating
diseases. In DC Dale, DD Federman, eds., ACP Medicine,
section 11, chap. 9. New York: WebMD.
Fassas A, et al., (2002). Hematopoietic stem cell
transplantation for multiple sclerosis: A retrospective study. Journal of Neurology, 249(8): 1088–1097.